Blackstone Group »

Lexeo Therapeutics shares owned by Blackstone Group

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Blackstone Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $11M 696k 15.68
2023-12-31 $9.3M 696k 13.42

More positions owned by Blackstone Group

Cheniere Energy Partners Com Unit (CQP)
Energy Transfer Com Ut Ltd Ptn (ET)
Corebridge Finl (CRBG)
Gates Indl Corp Ord Shs (GTES)
Chesapeake Energy Corp (CHK)
FirstEnergy (FE)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Targa Res Corp (TRGP)
MPLX Com Unit Rep Ltd (MPLX)
PG&E Corporation (PCG)
Cheniere Energy Com New (LNG)
Enterprise Products Partners (EPD)
Kinetik Holdings Com New Cl A (KNTK)
Western Midstream Partners L Com Unit Lp Int (WES)
Plains All Amern Pipeline L Unit Ltd Partn (PAA)

View all positions for Blackstone Group

Top funds holding Lexeo Therapeutics

Eventide Asset Management
Henderson Group
Citadel Advisors
Omega Fund Management
Adage Capital Partners GP
Braidwell
Artal Group
Blackstone Group
BlackRock
RA Capital Management
Millennium Management
Vanguard Group
Laurion Capital Management
Geode Capital Management
Cornell University

View all funds holding Lexeo Therapeutics